Sunitinib
Definition: Sunitinib, sold under the brand name Sutent, is an anti-cancer medication. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) in January 2006. source: Wikipedia
- ID
- 421192001
- ID date
- 14 Aug 2007
- Previous ID
- 10816311000001107
- Name
- Sunitinib